MedTrace Logo

Safety and Effectiveness of COVID-19 Vaccine in Kidney Transplant Recipients

NCT05156086 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 1000

Last updated 2021-12-15

No results posted yet for this study

Summary

The current study is a noninterventional prospective study examining the efficacy of additional dosage of the coronavirus disease 2019 (COVID-19) vaccine in kidney transplant recipients (KTRs).

Conditions

  • COVID-19 Vaccination
  • Renal Transplant

Interventions

DRUG

COVID-19 vaccine, booster

Additional dose of COVID-19 vaccine (booster shot)

Sponsors & Collaborators

  • Seoul National University Hospital

    lead OTHER

Eligibility

Min Age
12 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-11-16
Primary Completion
2022-08-01
Completion
2022-11-08
FDA Drug
Yes

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05156086 on ClinicalTrials.gov